Mood Group

Thanks to Emma Thorpe at Thorp Associates for this

Tuberculosis Drugs: Hopes Pinned on Renewed Government Investments in Emerging Economies Tuberculosis is a chronic condition that is often undermined, though it can be fatal if left unchecked. Thankfully, extensive awareness campaigns and initiatives by various governments to curb the menace is bearing fruit. Tuberculosis treatment helped prevent 49 million fatalities associated with the condition between 2000 and 2015. However, there are still some prominent diagnostic and treatment slits that continue. In 2015, approximately 6.1 million newly diagnosed tuberculosis cases were reported by national authorities of various countries and reported to World Health Organization. This high increase in tuberculosis cases during 2013–2015, was typically due to a 34% increase in tuberculosis cases notifications in India. Globally, there was 4.3 million new tuberculosis cases gap between incident and reported cases, out of which India, Indonesia, and Nigeria comprises almost half of these newly diagnosed cases impacting high revenue generation in tuberculosis drugs market. 

Request a sample copy of this report:https://goo.gl/ccUytS

In 2015, out of 580 thousand people who were eligible for multidrug resistance tuberculosis treatment, only 125 000 (20%) were registered. Five countries, namely India, China, the Russian Federation, Indonesia, and Nigeria account for over 60% of this gap.Worldwide, the multidrug resistance tuberculosis treatment success rate was 50-52% in 2013 and in 2015, approximately 55% of reported new tuberculosis patients had a documented HIV test result. The HIV-positive tuberculosis patients on an antiretroviral therapy was around 78%. This led to the wider understanding about the ailment and government and non-governmental organizations alike are focusing on developing tuberculosis preventive treatment and increasing their access to the general populace. Thus, it would boost the tuberculosis drugs market over the forecast period.%MCEPASTEBIN% With the significant increase in revenue of tuberculosis drugs market, over last decade, more than 10 chemical moiety have advanced into the clinical trial development pipeline, which include six new chemical moiety significantly and specifically developed for tuberculosis. Though there are molecules in clinical development phase, the global drug pipeline for tuberculosis is still not sufficient to address the unmet needs of treatment. Many pharmaceutical companies have produced molecules that are under clinical trials and the key challenges by any company to develop new product to treat tuberculosis and effects the tuberculosis drugs market are the needs for drugs in combination therapy, new trial strategies, studies on pediatric TB drugs, population and increased clinical trial capacity and clear regulatory guidelines. 

Request customization of the report:https://goo.gl/Po7O4N

High funding for research and development and clinical trials drugs to boost the tuberculosis drugs market There was around US$ 6.6 billion revenue accessible for tuberculosis care and prevention in many of the low and middle-income countries in 2016, out of which 84% was from domestic sources. However, national tuberculosis program (NTPs) in low income countries linger to depend on international donors or foreign healthcare agencies to fund them approximately 90%. Investments in low income countries and middle income countries declined by US$ 2 billion to US$ 8.3 billion, which was needed in 2016. There were many enhancements needed in overall healthcare financing to curb new tuberculosis cases proportionally boosting tuberculosis drugs market. Government expenditures on healthcare in specific to tuberculosis in 2014 were less than the World Health Organization set a benchmark of at least 6% of gross domestic product in around 150 countries. Private expenditures surpassed 45% of total healthcare expenditures in tuberculosis in 46 countries, which also includes 11 of the 30 high tuberculosis burden countries. Presently, there are around 13 vaccine candidates in clinical development, which include trial drugs for prevention of tuberculosis infection and trial drugs for prevention of tuberculosis disease in people with Latent Tuberculosis Disease. According to WHO, at least US$ 2 billion investment is needed every year for tuberculosis research and development. In stark contrast, capital investment during 2005–2014 was reported to be US$ 0.7 billion annually. Infusion of investments in research and development would significantly improve the tuberculosis drugs market outlook.

 View this full report: https://goo.gl/UAdJVe

 About Coherent Market Insights:

Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.

DBV Technologies has an exciting opportunity for a Product Manager / Senior Product Manager - Marketing Development in our Summit, NJ location.  https://www.linkedin.com/jobs/cap/view/303726597/?pathWildcard=303726597&trk=job_capjs

I have more than 20 years business leadership experience within the Pharmaceutical, Healthcare and Life Sciences Industry. During my career I have worked with various organisations, from SME through to some of the most well-known global organisations

Dear members, I am currently looking for positions as a clinical trial assistant or clinical research assistant. I want to learn on the job and begin a new career in clinical trials. Any advice or leads would be greatly appreciated. Thank you!

Good Morning Ravinder, drop me an email to Luke.Blaney@rbwconsulting.com and we can speak from there. I look forward to hearing from you soon.

I have twelve year of experience in pharmaceutical quality control. Presently looking QMS , OOS,OOT,Deviations,Disregards. I am looking for a compliance job in pharmaceutical industry.I want  more challenging job in this field where I develop my carrier and also willing to relocate. Previously I  have worked with CIPLA Ltd , Glenmark Pharmaceutical Ltd, USV Ltd, Morpean Lab Ltd.

Could you share your email id or alternatively may mail me at saybal@gmail.com

I am looking forward to connect with people who are currently working in Saudi Arabia and GCC countries with proven experience in Pharmaceutical companies.

Kayla Garcia SUMMARY OF QUALIFICATIONS·         Highly motivated individual with experience in sales, marketing, customer service, and operations management·         Able to work both independently and in a team environment toward meeting established objectives·         Goal oriented while remaining customer focused·         Maintain ability to establish rapport with customers by quickly identifying their needs and presenting appropriate solutions PROFESSIONAL EXPERIENCEGlobalSecur Travel Security – Weston, FL                                                      9/2016 – PresentSales Manager ·         Responsible for identifying and developing new business prospects for a patented smart phone application·         Develop new accounts and maintain growth of existing accounts·         Maintain weekly solicitation phone calls and travel agency presentations·         Participate in weekly sales strategy meetings as assigned by director of sales The Cheesecake Factory – Sawgrass, FL                                                          8/2016 – PresentServer/Shift Leader /Designated Trainer (Part Time) ·         Responsible for selling food/services to provide an exceptional dining experience.·         Trained new employees to produce high sales capacity to generate revenue.·         Responsible for managing a group of 10-12 people making sure all duties are fulfilled. Interactive Response Technologies – Miramar, FL                                           1/2012 – 2/2013Loan Approval/Sales Representative/Customer Service (Part Time)·         Worked on account Money Mutual account and was responsible for approving short term loans·         Promoted to another account Purchasing Power within 4 months·         Responsible for selling electronics and appliances over the phone to qualified government employees·         Responsible for all sales transactions, purchases, setting up allotments, and payment plans customized to fit the customer’s needs while increasing company revenue EDUCATIONFlorida International University – Miami, FL                                           12/2016·         Bachelors Degree in Psychology ·         Dean’s List Award Recipient VOLUNTEER WORK·         Volunteered at many community events such as Relay for Life, Pines Night Out, and Chili Cook Off as a stand by medic certified in CPR/ AED training by the American Heart Association. ·         Volunteered at blood drives making sure all donors were fed, hydrated, and iron count was appropriate for donation. COMPUTER SKILLSProficient in Word, Excel, PowerPoint, and OutlookKayla Garcia SUMMARY OF QUALIFICATIONS·         Highly motivated individual with experience in sales, marketing, customer service, and operations management·         Able to work both independently and in a team environment toward meeting established objectives·         Goal oriented while remaining customer focused·         Maintain ability to establish rapport with customers by quickly identifying their needs and presenting appropriate solutions PROFESSIONAL EXPERIENCEGlobalSecur Travel Security – Weston, FL                                                      9/2016 – PresentSales Manager ·         Responsible for identifying and developing new business prospects for a patented smart phone application·         Develop new accounts and maintain growth of existing accounts·         Maintain weekly solicitation phone calls and travel agency presentations·         Participate in weekly sales strategy meetings as assigned by director of sales The Cheesecake Factory – Sawgrass, FL                                                          8/2016 – PresentServer/Shift Leader /Designated Trainer (Part Time) ·         Responsible for selling food/services to provide an exceptional dining experience.·         Trained new employees to produce high sales capacity to generate revenue.·         Responsible for managing a group of 10-12 people making sure all duties are fulfilled. Interactive Response Technologies – Miramar, FL                                           1/2012 – 2/2013Loan Approval/Sales Representative/Customer Service (Part Time)·         Worked on account Money Mutual account and was responsible for approving short term loans·         Promoted to another account Purchasing Power within 4 months·         Responsible for selling electronics and appliances over the phone to qualified government employees·         Responsible for all sales transactions, purchases, setting up allotments, and payment plans customized to fit the customer’s needs while increasing company revenue EDUCATIONFlorida International University – Miami, FL                                           12/2016·         Bachelors Degree in Psychology ·         Dean’s List Award Recipient VOLUNTEER WORK·         Volunteered at many community events such as Relay for Life, Pines Night Out, and Chili Cook Off as a stand by medic certified in CPR/ AED training by the American Heart Association. ·         Volunteered at blood drives making sure all donors were fed, hydrated, and iron count was appropriate for donation. COMPUTER SKILLSProficient in Word, Excel, PowerPoint, and Outlook

Last month, eyeforpharma were joined by medical affairs leaders from Sanofi, GSK and Roche to discuss the evolving role and future of medical affairs departments. You can now listen back to the discussion anytime here: https://goo.gl/dEzXCP If this discussion has sparked your interest, you should join our in-depth program at eyeforpharma’s Medical Affairs summit, 14-16 March in Barcelona, where we will help your department to become a strategic partner. Download the full agenda today: https://goo.gl/q4QZhL

I am looking for a new challenging job within pharma industry/biotech (Europe, except UK). I have a long-standing expertise in translational research within oncology/immune diseases, basic cell & molecular biology as well as in project management (pharma industry). For details, please visit my web site at https://www.linkedin.com/in/svetlana-panina-6b6a2216/

This is my first time on this site, I am a recruitment resourcer with KPC, KPC is a an engineering and consulting firm  that work on start up projects with the pharmaceutical companies. We specialize in commissioning , qualification and validation. brian.duffy@kpc-international.com(0) 21 2363152

Cancer biomarkers are biomolecules that specifies the existence of cancer or cancerous cells in the body. These are generally molecules that are released due to the presence of a tumor or a particular indication in the body to the presence of cancer. These molecules are densely distributed in tissues, urine, serum, blood, and other body fluids. Their expression levels serve as the basis or indication of any abnormal process or a disease.

The market size of the global cancer biomarkers market was valued at $6,521 million in 2015 and is estimated to grow at a CAGR of 13% over the forecast period to reach $15,737 million in 2022. Market growth is attributed to the increasing incidences of cancers such as lung cancer, breast cancer, and prostate cancer among others coupled with growing importance of biological and targeted drug therapies and technological advancements in the field of cancer treatment. However, unregulated government laws and reimbursement policies; as well as high cost of drug development and threat of failure are anticipated to have an adverse effect on the market growth. Nevertheless, advancement in cancer drugs research and significant unmet need in cancer diagnosis are estimated to overshadow these restraints.

The global cancer biomarkers market is segmented based on profiling technology, biomolecules, cancer type, application, and geography. By profiling technology, the market is segmented into omic technologies, imaging technologies, immunoassays and cytogenetics based tests. Based on biomolecules, the market is segmented into genetic biomarkers, protein biomarkers, and glycoprotein biomarkers. Amongst these, genetic biomarkers are widely used in the market owing to better diagnostic and therapeutic usage as compared to protein and glycoprotein biomarkers.

The various cancer types include breast cancer, lung cancer, prostate cancer, colorectal cancer, stomach cancer, and others. Amongst these, lung cancer is the major cancer type where biomarkers are being used for detection. Owing to high tobacco consumption and smoking, lung cancer has increased at an alarming rate. CEACAM-5/CD66e, Cytokeratin 19, EGF R/ErbB1, Enolase 2/Neuron-specific Enolase, Lactate Dehydrogenase A/LDHA, Lactate Dehydrogenase B/LDHB, Napsin A and PDGFRL are some of the major cancer biomarkers used for lung cancer detection.

Geographically, North America is the leading revenue generating region, due to high incidence rate of cancer, growth in awareness towards cancer and higher cancer biomarker testing. Asia-Pacific is growing at the fastest CAGR due to rise in awareness, increased disposable income, and affordability for advanced cancer treatments.

Get Sample Copy @ http://www.researchbeam.com/cancer-biomarkers-market/request-sample

Companies have adopted collaboration and partnership as their key development strategies. Increase in focus on collaboration and partnership is mainly for the development of innovative technologies in the field of cancer biomarkers. In May 2016, Roche received an approval by FDA for its first anti-PD-L1 cancer immunotherapy namely Tecentriq (atezolizumab), thereby expanding its product portfolio.

KEY BENEFITS FOR STAKEHOLDERS:

The drivers, restraints, and opportunities in the global cancer biomarkers market are expected to help in understanding the market behavior better.

The market estimations are a result of high-end analysis of the key market segments for the period of 2014–2022

Projections in the report are made by analyzing the current market trends and future market potential for the forecast period in terms of value. The analysis helps in understanding the strategies adopted by various companies for the growth of the global cancer biomarkers market.

Country level analysis has been done to provide micro market sizing of cancer biomarkers in different regions

Porter's five forces model gives an in-depth analysis of bargaining power of buyers and suppliers, threats of new entrants & substitutes, and competition amongst the key market players.

Ask for Discount @ http://www.researchbeam.com/cancer-biomarkers-market/purchase-enquiry

Research Beam added report on “Global Exosome Diagnostic and Therapeutic Market Technology, Trends, Analysis, Growth and Research – Exosome Diagnostic and Therapeutic Market by Application (Diagnostic and Therapeutic), Product (Instrument, Reagent, and Software) and End-User (Cancer Institute, Hospital, Diagnostic Center, and Others) - Global Opportunity Analysis and Industry Forecasts, 2014-2022”

Exosomes are small extracellular vesicles present in various body fluids such as saliva, urine, blood, and breast milk. These vesicles play an important role in intercellular communication processes and have specific composition of proteins, lipids, messenger RNA (mRNA), and micro RNA. Currently, exosomes have great potential to be used as a vehicle for drug delivery and a biomarker for the diagnosis of various diseases and for therapeutic use. Moreover, exosomes offer an alternative pathway for invasive biopsy used in the diagnosis and management of different types of cancer.

The global exosome diagnostic and therapeutic market is expected to reach $367 million by 2022, growing at a CAGR of 37.8% from 2016 to 2022. Increase in prevalence of cancer, growth in initiatives implemented by the government and non-government associations for rise in health awareness play a pivotal role in the growth of the global exosome diagnostic and therapeutic market. Moreover, technological advancements in exosomes isolation, analytical procedures, and innovative and advanced applications of exosomes also supports to the growth of the market. Stringent government regulations for the approval of exosomes diagnostic and therapeutic products and low awareness about the applications of exosomes hamper the market growth.

The world exosomes diagnostic and therapeutic market is segmented based on application, product, end user, and geography. Based on the application, it is divided into diagnostic and therapeutic applications. Based on the product, it is classified into instrument, reagents, and software used in the isolation and analysis of exosomes from cells and tissues. Based on end user, the market is segmented into cancer institute, institutes, hospitals, diagnostic centers, and others (medical universities, and not-for-profit organizations). Geographically, the market is segmented across four major regions, such as North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, and rest of Europe), Asia-Pacific (China, Japan, and rest of Asia-Pacific) and LAMEA.

Get Sample Copy @ http://www.researchbeam.com/exosome-diagnostic-and-therapeutic-market/request-sample

Key benefits

The study provides an in-depth analysis of the exosome diagnostic and therapeutic market, with current trends and future estimations to elucidate the imminent investment pockets.

The report provides a quantitative analysis from 2014 to 2022 to enable the stakeholders to capitalize on prevailing market opportunities.

Extensive market analysis by product assist in the treatment of various chronic and infectious diseases such as cancer, cardiovascular diseases, and other diseases.

Competitive intelligence highlights the business practices followed by leading market players across various geographic regions.

Key market players are profiled and their strategies are analyzed thoroughly, which predicts the competitive outlook of the market.

Ask for Discount @ http://www.researchbeam.com/exosome-diagnostic-and-therapeutic-market/purchase-enquiry

The Global Polyimide Film Consumption 2016 Market Research Report is a professional and in-depth study on the current state of the Polyimide Film market.

Read Full report with TOC@ http://www.qyresearchgroup.com/market-analysis/global-polyimide-film-market-2016-industry-trends-sales.html

First, the report provides a basic overview of the Polyimide Film industry including definitions, classifications, applications and industry chain structure. And development policies and plans are discussed as well as manufacturing processes and cost structures.

Secondly, the report states the global Polyimide Film market size (volume and value), and the segment markets by regions, types, applications and companies are also discussed.

Third, the Polyimide Film market analysis is provided for major regions including USA, Europe, China and Japan, and other regions can be added. For each region, market size and end users are analyzed as well as segment markets by types, applications and companies.

Then, the report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the Polyimide Film industry development trends and marketing channels are analyzed.

Finally, the feasibility of new investment projects is assessed, and overall research conclusions are offered.

Click Here To download Full report sample 

In a word, the report provides major statistics on the state of the industry and is a valuable source of guidance and direction for companies and individuals interested in the market.

The MSL field can be quite competitive. You should get involved (or at least in communication) with employers of MSL like pharmaceutical companies, manufacturers of medical devices, or some other companies that provide products or services to medical facilities.  I have some colleagues in the industry that recommend to explore your options by using a reputable recruiter or try to get some insight or recommendations through referrals in your industry.  You can also send your resume with cover letter to some recruiters like doctorschoiceplacement.com, hospitalrecruiting.com/ who are good at filling MSL positions. Best of luck for your future.

Hello everyone, I am not going to write down all the info regarding my background as a simple click will showw you that information via my profile. I am trying to break into the role of MSL and it is seeming to be very difficult. I have bought books, which I am still in the process of reading, applied to many jobs and I am just trying to gain some insight into any tricks of the trade so to speak that others might have. Really I am looking to start a dialogue with like-minded individuals, people in the role already, recruiters and people in the industry. I figured this is as good aplace to start. 

How direct-to- consumer advertising, corporate malfeasance, and conflicts of interest at the FDA have given rise to a false sense of security for women who use some forms of hormonal birth control.  https://www.beaconreader.com/dan-walter/safe-enough